Cite

HARVARD Citation

    Linn, S. et al. (n.d.). A Post‐marketing Adverse Effect of One of the New Anti‐Hepatitis C Medications ‐ Clinical Case Series. American journal of gastroenterology. p. . [Online]. 
  
Back to record